Yusuke Kashiwado

Years Active: 2022-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Yusuke Kashiwado, Yasutaka Kimoto, Kenji Oku, Mari Yamamoto, Shiro Ohshima, Satoshi Ito, Takahiko Horiuchi, Tsutomu Takeuchi
Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan. Modern rheumatology (2023)
Yusuke Kashiwado, Yasutaka Kimoto, Takuya Sawabe, Kensuke Irino, Shota Nakano, Junki Hiura, Qiaolei Wang, Shotaro Kawano, Masahiro Ayano, Hiroki Mitoma, Nobuyuki Ono, Yojiro Arinobu, Hiroaki Niiro, Taeko Hotta, Dongchon Kang, Koichi Akashi, Shiro Ohshima, Tsutomu Takeuchi, Takahiko Horiuchi
Antibody Response to SARS-CoV-2 mRNA Vaccines in Patients with Rheumatic Diseases in Japan: Interim Analysis of a Multicenter Cohort Study. Modern rheumatology (2022)
Chihiro Saiki, Yusuke Kashiwado, Taku Yokoyama, Masahiro Ayano, Keisuke Imabayashi, Shotaro Kawano, Kazuhiko Higashioka, Yasutaka Kimoto, Mitsuhiro Fukata, Hiroki Mitoma, Nobuyuki Ono, Yojiro Arinobu, Koichi Akashi, Takahiko Horiuchi, Hiroaki Niiro
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus. Modern rheumatology case reports 6 (2) (2022)

Yusuke Kashiwado.css-eqlu8i{font-size:small;padding-left:4px;}